The status quo of excessive proliferation of generic drugs，Out of the attention of regulatory authorities。

 

  September 14，The State Food and Drug Administration (hereinafter referred to as the State Administration of Food and Drug Administration) issued an announcement，The bureau discovers when combing the drugs that have been listed in 2012-2014，stake online sports bettingstake betting appmetronidazole、glucose、Sodium chloride and other 282 kinds of drugs are over -repeated。

 

  "Daily Economic News" reporter noticed，Among them, more than 100 varieties of products are listed and circulated。Researcher Cao Jian, a researcher at Tsinghua University Medical Management Research Center，Low drug approval standards before 2007，Many small and medium -sized enterprises have low production technology content、Demand with larger demand，Relying on low prices in the market to compete。

 

  Glucose production approval exceeds 2000

 

  It is understood，Monitoring statistics of the State Administration of Food and Drug Administration comes from 65 cities across the country、6200 sample pharmacies，covering chemicals and biological products approved by November 25, 2014，Total 2750 general name varieties，A number of products involved in existing registration approval number products is about 110,000。

 

  The Food and Drug Administration analyzes the use of drug sales during the sample hospital for 3 years.，At present, there are 2,241 varieties in normal circulation，Among them, 21 varieties have more than 100 manufacturers' stake betting appproducts to be listed，70 varieties all have 50-99 manufacturers of products to be listed Stake Sports Bettingand circulated，9 varieties have more than 1,000 manufacturers' products to be listed and circulated。Take glucose as an example，The number of this drug has been approved by 2043，392 companies produced，CMEI monitoring for three years in sales, 828。

 

   & ldquo; This is not a new phenomenon，Many varieties have repeatedly boarded the over -duplicate directory。& rdquo; A middle -level manager of a large pharmaceutical company in Jiangsu told reporters，2012、The State Administration of Food and Drug Administration in 2014 has announced 25、80 excessive repetitive varieties and registered declarations，metronidazole、Aspirin、Cobes and other lists are famous，But there are still many manufacturers who declare registration。

 

 R & D low -end low -end

 

  2001-2006，To solve the problem of insufficient supply of the drug market，my country's drug approval all the way to galloping all the way。According to incomplete statistics，Among the generic drugs circulating on the market，More than 90 % of the drugs approved before 2007。

 

   & ldquo; Many companies are piled up with basic drugs with high demand for medication。& rdquo; Stake Sports BettingCao Jian told reporters，The research and development stake sports betting apptime of innovative drugs is usually more than ten years、Investment big，There is a lot of challenges to the funds and R & D strength of the enterprise。Overall，At present, domestic pharmaceutical companies are generally small、Innovative ability，I can only make profits by generic drugs。

 

  The direct result of the competition is the price war。The aforementioned person said，If a drug manufacturer is easier to make a profit within 10，It is difficult to have profits when you reach 30，If there are 50 or even hundreds of，Almost disorderly competition。

 

   & ldquo; Relatively speaking，Large enterprises have stronger strength，Production costs will be higher。But the winning price of some small companies is lower than our cost，Some varieties simply don't do it。& rdquo;。

 

  Cao Jian thinks，Checking storms, which started in the second half of last year, has caused a large number of generic drug companies to automatically withdraw new drug registration applications，The following consistency evaluation and & ldquo; two votes & rdquo;，The industry will usher in a shuffle in the survival of the fittest。